STOCK TITAN

SeaStar Medical misses Nasdaq’s $2.5M equity requirement

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

SeaStar Medical Holding Corporation received a Nasdaq notice stating it does not meet the $2.5 million stockholders’ equity requirement for continued listing. The rule applies to companies with a market value of listed securities below $35 million and annual net income below $500,000. The notice was based on information in the company’s quarterly report for the quarter ended September 30, 2026.

SeaStar Medical plans to submit a compliance plan by January 4, 2027, within 45 calendar days of the notice. If Nasdaq accepts the plan, staff may grant an extension of 180 calendar days from November 20, 2026, to regain compliance. The notice has no immediate effect on the company’s continued listing, subject to other listing requirements; Nasdaq said the common stock would be subject to delisting if staff rejects the plan.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointNasdaq’s equity-listing deficiency carries a January 4, 2027 compliance-plan deadline.

Filing Explained

The filing also says that if Nasdaq rejects SeaStar Medical’s compliance plan, the company may appeal the staff’s decision to a Nasdaq Hearing Panel.

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Stockholders’ equity requirement $2.5 million Nasdaq continued-listing requirement
Market value threshold $35 million Rule applies to companies with a market value of listed securities below this level
Annual net income threshold $500,000 Rule applies to companies with annual net income below this level
Compliance-plan submission period 45 calendar days The company has until January 4, 2027, to submit its plan
Potential extension 180 calendar days Nasdaq staff may grant an extension if it accepts the plan
Stockholders’ Equity Requirement regulatory
"minimum of $2.5 million in stockholder’s equity for continued listing"
A stockholders’ equity requirement is a minimum amount of net assets — assets minus liabilities — that a company must keep on its balance sheet to meet rules set by regulators, lenders or stock exchanges. Think of it as a required safety buffer or minimum bank balance that shows the company has enough of its own capital to absorb losses; falling below it can limit dividends, trigger covenants or risk sanctions, so investors watch it as a sign of financial health and compliance.
Compliance Plan regulatory
"submit a plan to regain compliance with the Stockholders’ Equity Requirement"
A compliance plan is a company's documented roadmap of rules, procedures and checks designed to ensure it follows laws, industry rules and internal policies. Think of it as an instruction manual and regular checklist that helps prevent costly mistakes, fines or business disruptions by flagging problems early and guiding corrective action. Investors watch these plans because a clear, enforced plan lowers legal and reputational risk and indicates stronger management and governance.
Nasdaq Hearing Panel regulatory
"appeal the Staff’s determination to a Nasdaq Hearing Panel"
A Nasdaq hearing panel is a group of independent reviewers who decide whether a publicly listed company has broken the exchange’s rules and what penalties, if any, should apply. Think of it like a neighborhood committee that reviews complaints and can impose fines, require fixes, or remove a member; for investors, the panel’s rulings can affect whether a stock keeps trading, faces suspension, or suffers reputational and price impact.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did SeaStar Medical (ICU) receive a Nasdaq compliance notice?

Nasdaq said SeaStar Medical does not meet the $2.5 million stockholders’ equity requirement for continued listing. The rule applies to companies with a market value of listed securities below $35 million and annual net income below $500,000. The notice was based on information in the company’s quarterly report for the quarter ended September 30, 2026.

What happens if Nasdaq rejects SeaStar Medical’s compliance plan?

If Nasdaq staff rejects the plan, the common stock would be subject to delisting, and the company may appeal the staff determination to a Nasdaq Hearing Panel.

How much time could SeaStar Medical get to regain Nasdaq compliance?

If staff accepts the plan, it may grant an extension of 180 calendar days from November 20, 2026, for the company to regain compliance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001831868 0001831868 2026-11-20 2026-11-20 0001831868 icu:CommonStockCustomMember 2026-11-20 2026-11-20 0001831868 icu:Warrants250WarrantsExercisableForOneShareOfCommonStockFor2875PerShareCustomMember 2026-11-20 2026-11-20
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

FORM 8-K

 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 20, 2026
 
SeaStar Medical Holding Corporation
 
(Exact name of Registrant as Specified in Its Charter)
 
 
 
Delaware
001-39927
85-3681132
(State or Other Jurisdiction
(Commission File Number)
(IRS Employer
of Incorporation)
 
Identification No.)
3513 Brighton Blvd,
   
Suite 410
   
Denver, Colorado
 
80216
(Address of Principal Executive Offices)
 
(Zip Code)
 
 
Registrant’s Telephone Number, Including Area Code: 844 427-8100
 
(Former Name or Former Address, if Changed Since Last Report)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
   
Trading
   
Title of each class
 
Symbol(s)
 
Name of each exchange on which registered
Common Stock par value $0.0001 per share
 
ICU
 
The Nasdaq Stock Market LLC
Warrants, 250 warrants exercisable for one share of Common Stock for $2,875 per share
 
ICUCW
 
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 3.01  Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
 
On November 20, 2026, SeaStar Medical Holding Corporation (the “Company”) received a letter (the “Notice”) from the  Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that based on information provided in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market with a market value of listed securities of less than $35 million and annual net income of less than $500,000 to maintain a minimum of $2.5 million in stockholder’s equity for continued listing (the “Stockholders’ Equity Requirement”).
 
In accordance with Nasdaq rules, the Company was provided 45 calendar days, or until January 4, 2027, to submit a plan to regain compliance with the Stockholders’ Equity Requirement (the “Compliance Plan”). The Company plans to submit a Compliance Plan. If the Compliance Plan is determined to be acceptable to the Staff, the Staff would have the discretion to grant the Company an extension of 180 calendar days from the date of the Notice to regain compliance with the Stockholders’ Equity Requirement. There can be no assurance that the Compliance Plan will be accepted or that, if it is, the Company will be able to regain compliance. The Notice has no immediate effect on the Company’s continued listing on The Nasdaq Capital Market, subject to the Company’s compliance with other continued listing requirements. If the Staff does not accept the Compliance Plan, the Staff will provide written notification to the Company that the Compliance Plan has been rejected and that the Common Stock is subject to delisting. At that time, the Company may appeal the Staff’s determination to a Nasdaq Hearing Panel.
 
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
SeaStar Medical Holding Corporation
   
By:
/s/ Eric Schlorff
Date:
November 20, 2026
Name:
Eric Schlorff
   
Title:
Chief Executive Officer
       
 
 

Filing Exhibits & Attachments

4 documents

Keep reading